Regeneron Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
02.02.26
/
50%
€639.20
Target price
02.02.27
€800.09
Performance (%)
2.31%
Price
20:02
€653.00
Summary
This prediction is currently active. With a performance of 2.31%, the BUY prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc. is trending in the right direction. Dividends of €0.94 are taken into consideration when calculating the performance. This prediction currently runs until 02.02.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.423% | 3.423% |
| iShares Core DAX® | 1,60 % | -7,45 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % |
| iShares S&P 500 | -0,39 % | -2,34 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at JPMorgan Chase & Co. from $850.00 to $950.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.50
09.06.25
09.06.25
€700.56
09.06.26
09.06.26
47.51%
20:02
20:02
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€586.00
31.03.25
31.03.25
€922.40
31.03.26
31.03.26
13.34%
01.04.26
01.04.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.60
24.10.24
24.10.24
€1,064.9
24.10.25
24.10.25
-42.87%
25.10.25
25.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€990.00
02.08.24
02.08.24
€1,099.6
02.08.25
02.08.25
-51.29%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€974.20
17.06.24
17.06.24
€1,072.3
17.06.25
17.06.25
-54.45%
18.06.25
18.06.25